Shanghai, China — October 2026
NCC Medical participated in OCIN 2026 and the Annual Academic Conference of the Stroke Branch of the Shanghai Medical Association, held from October 22 to 25, 2026, at the Shanghai International Convention Center. The event brought together clinical specialists and researchers to discuss developments in stroke care, intracranial aneurysms, cerebrovascular malformations, and neurointerventional treatment.
Under the theme of the “future angiography suite,” the conference addressed how artificial intelligence, interventional robotics, optical coherence tomography, and intraoperative neurophysiological monitoring may contribute to more integrated and function-oriented interventional care.

During the conference, NCC Medical contributed to the academic program through two presentations:
The presentations focused on the role of intraoperative neurophysiological monitoring in providing functional information during neurointerventional procedures. Whereas imaging primarily depicts anatomical structures, electrophysiological monitoring can provide real-time information about neural function. Used together, these two forms of information may offer complementary support for intraoperative assessment and clinical decision-making.
On the morning of October 24, during OCIN 2026, a signing and unveiling ceremony was held for the Interventional Electrophysiology Innovation and Translation Center. The center is being jointly established by:
The collaboration is intended to connect clinical resources, research and development capabilities, and technology-translation resources. Its proposed innovation pathway extends from the identification of clinical needs and generation of ideas to technical development, prototype validation, and industrial implementation.

The partners will focus on intraoperative neurophysiological monitoring for interventional procedures, with the stated goals of supporting original technology development, promoting the standardization of related techniques, and facilitating the translation of interventional neurophysiological monitoring technologies into clinical use.
The ceremony was attended by representatives from the participating clinical, research, industry, and public-sector organizations, as well as other invited guests. Their participation reflected the shared interest in connecting clinical needs with research, engineering, and technology translation.
In the “Future Angiography Suite” session, Liu Minghui, Director of the Shenhu Qishen Division of Shanghai NCC Electrical Co., Ltd., presented “A New Paradigm for the Future Angiography Suite: The Value and Application of Intraoperative Electrophysiology in Interventional Procedures.”
The presentation reviewed the development of intraoperative neurophysiological monitoring, its application in neurointerventional procedures, and the role of clinical data and representative cases in demonstrating its potential value. It also outlined possible implementation pathways for integrating intraoperative electrophysiology into future angiography-suite workflows.
The proposed framework included three areas:
The presentation also discussed potential equipment and consumable directions, including devices designed for interventional procedures, radiolucent electrodes, and a centralized monitoring system. The reported design considerations for radiolucent electrodes included reducing obstruction and artifacts in imaging, supporting integrated connections, using an embedded link chip to help reduce operating errors, and applying a twisted-wire design to improve resistance to interference.
A centralized monitoring system was discussed as a potential tool for coordinated neurological monitoring within a hospital and for collaboration across multiple centers. These points were presented as technology and implementation directions rather than as claims of established clinical performance.
NCC Medical’s participation in OCIN 2026 brought together three related areas of work: academic exchange on intraoperative neurophysiology, collaboration between clinical and engineering teams, and discussion of technology pathways for future angiography suites.
Through continued dialogue with clinicians, researchers, and technology partners, NCC Medical aims to contribute to discussions on how functional monitoring may complement imaging during interventional procedures. The company will continue to explore how clinically relevant requirements can inform practical monitoring solutions and responsible innovation in neurointerventional care.
Copyright © NCC Medical Co., Ltd. - Privacy policy